TABLE 2.
Linear regression models for girls showing the effects of maternal weight loss on infant weight and length gain from 0 to 24 wk in BAN mother-infant pairs included in the primary analysis of the effects of maternal weight loss on infant growth1
| Weight gain, kg |
Length gain, cm |
|||||||||||
| Crude, n = 633 |
Adjusted, n = 609 |
Crude, n = 632 |
Adjusted, n = 608 |
|||||||||
| Coefficient | 95% CI | P value | Coefficient | 95% CI | P value | Coefficient | 95% CI | P value | Coefficient | 95% CI | P value | |
| Birth weight or length | −0.26 | (−0.43, −0.10) | 0.002 | −0.30 | (−0.47, −0.13) | 0.001 | −0.46 | (−0.55, −0.37) | <0.001 | −0.46 | (−0.56, −0.36) | <0.001 |
| Maternal weight loss | −0.97 | (−1.86, −0.08) | 0.03 | −1.29 | (−2.20, −0.38) | 0.01 | −2.38 | (−4.83, 0.08) | 0.06 | −3.36 | (−5.88, −0.85) | 0.01 |
| Maternal BMI at 2 wk | 0.03 | (−0.001, 0.06) | 0.06 | 0.02 | (−0.01, 0.05) | 0.12 | −0.005 | (−0.08, 0.07) | 0.90 | −0.03 | (−0.11, 0.05) | 0.49 |
| Maternal weight loss × BMI | 0.04 | (0.004, 0.08) | 0.03 | 0.06 | (0.02, 0.09) | 0.01 | 0.1 | (−0.01, 0.20) | 0.07 | 0.14 | (0.03, 0.25) | 0.01 |
| CD4 cells < cells/mm3 | 0.03 | (−0.10, 0.16) | 0.70 | −0.19 | (−0.55, 0.17) | 0.31 | ||||||
| Fever | 0.01 | (−0.06, 0.07) | 0.84 | 0.11 | (−0.07, 0.28) | 0.23 | ||||||
| Vomiting | −0.0005 | (−0.13, 0.13) | 1.00 | −0.01 | (−0.38, 0.37) | 0.98 | ||||||
| Diarrhea | −0.03 | (−0.16, 0.10) | 0.63 | −0.003 | (−0.36, 0.35) | 0.99 | ||||||
| Primiparous | −0.13 | (−0.34, 0.07) | 0.20 | 0.21 | (−0.35, 0.76) | 0.46 | ||||||
| Birth month (ref: September, October, November) | ||||||||||||
| January | 0.04 | (−0.21, 0.28) | 0.78 | 0.04 | (−0.66, 0.73) | 0.92 | ||||||
| February | 0.32 | (0.05, 0.59) | 0.02 | 0.66 | (−0.09, 1.41) | 0.08 | ||||||
| March | −0.02 | (−0.28, 0.24) | 0.87 | −0.32 | (−1.05, 0.41) | 0.39 | ||||||
| April | 0.14 | (−0.11, 0.39) | 0.26 | −0.08 | (−0.78, 0.61) | 0.82 | ||||||
| May | 0.09 | (−0.14, 0.32) | 0.43 | 0.35 | (−0.28, 0.98) | 0.27 | ||||||
| June | 0.17 | (−0.06, 0.39) | 0.14 | 0.64 | (0.02, 1.26) | 0.04 | ||||||
| July | 0.42 | (0.17, 0.66) | 0.001 | 0.16 | (−0.52, 0.84) | 0.64 | ||||||
| August | 0.13 | (−0.09, 0.35) | 0.25 | 0.88 | (0.28, 1.49) | 0.004 | ||||||
| December | 0.23 | (−0.04, 0.49) | 0.09 | 0.21 | (−0.52, 0.94) | 0.57 | ||||||
| Married | −0.05 | (−0.29, 0.19) | 0.70 | 0.10 | (−0.56, 0.76) | 0.77 | ||||||
| Education | 0.05 | (−0.08, 0.18) | 0.42 | 0.16 | (−0.20, 0.52) | 0.38 | ||||||
| Maternal ARV intervention | −0.04 | (−0.20, 0.11) | 0.58 | −0.43 | (−0.87, 0.02) | 0.06 | ||||||
| Maternal LNS intervention | 0.08 | (−0.05, 0.20) | 0.22 | 0.21 | (−0.12, 0.55) | 0.21 | ||||||
| Infant ARV intervention | −0.11 | (−0.26, 0.05) | 0.18 | −0.58 | (−1.01, −0.15) | 0.01 | ||||||
| Intercept | 4.06 | (3.32, 4.80) | <0.001 | 4.22 | (3.42, 5.01) | <0.001 | 37.64 | (33.07, 42.21) | <0.001 | 38.03 | (33.21, 42.86) | <0.001 |
1
ARV, antiretroviral drug; BAN, Breastfeeding, Antiretrovirals, and Nutrition; LNS, lipid-based nutrient supplement.